Mr. Alexander Cross

Cytopharm Inc.

Oakland, CA

Online Roster Bio

Has spent a nearly 20-year career as a consultant for the pharmaceutical and biotechnology industries. Also presently serves as principal of NDA Parnters. Previously served as president, CEO, EVP and COO of Zoecon Corp. Dr. Cross holds 109 issued United States patents. He also serves on the board of Ligand Pharmaceuticals Inc.

  • 2005 Second Quarter

Added to: Nastech Pharmaceutical Co. - Bothell, WA

Nastech is focused on a molecular biology-based intranasal drug delivery system. Revenues are $2 million.